Dr. Reddy’s Laboratories is a leading API CDMO headquartered in Hyderabad, India. Founded in 1984, Dr. Reddy’s Laboratories develops and manufactures complex APIs — such as steroids, peptides, complex long chain molecules, and HPAPIs — for clients worldwide. The company maintains a portfolio of over 150 APIs across a wide range of therapeutics categories, including diabetes, cardiovascular, and oncology. They have eight API facilities sites worldwide that provide GMP manufacturing for clients in more than 80 countries.